Results 121 to 130 of about 25,328 (236)

In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China.

open access: yesInternational Journal of Antimicrobial Agents
INTRODUCTION To date, the global prevalence of New Delhi metallo-β-lactamase (NDM) in carbapenem-resistant Enterobacterales (CRE) has been of concern, which is not inhibited by classical β-lactamase inhibitors (BLIs).
Xinmeng Liu   +15 more
semanticscholar   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study

open access: yesInfection and Drug Resistance
Chen-Huan Yu,1 Mao-Song Tsai,2 Chun-Hsing Liao,2 Chia-Jui Yang2 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Infectious Disease, Department of Internal Medicine, Far Eastern Memorial Hospital, New
Yu CH, Tsai MS, Liao CH, Yang CJ
doaj  

Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: a systematic review and meta-analysis.

open access: yesJournal of Global Antimicrobial Resistance
OBJECTIVES To meta-analyze the clinical efficacy of piperacillin-tazobactam vs. carbapenems for treating hospitalized patients affected by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bloodstream infections (BSIs).
M. Gatti, P. Cojutti, F. Pea
semanticscholar   +1 more source

Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa Epidemic Infections in Eastern Europe: A Systematic Literature Review

open access: yesAntibiotics
Background: Antimicrobial resistance is a major global public health challenge, particularly with the rise of carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa (CRPA).
M. Piotrowski   +3 more
semanticscholar   +1 more source

Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients

open access: yesAntibiotics
We evaluated the activities of aztreonam/avibactam and recently approved β-lactamase inhibitor combinations (BLICs) to compare the antimicrobial susceptibility patterns of Enterobacterales and Pseudomonas aeruginosa isolated from intensive care unit (ICU)
H. Sader   +4 more
semanticscholar   +1 more source

Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysis

open access: yesSaudi Pharmaceutical Journal
Antimicrobial resistance is a significant public health issue. In addressing the threat of multidrug resistant bacterial infections, carbapenems have been used.
Ahmad A. Alshehri, A. Irekeola
semanticscholar   +1 more source

Beta-Lactam Resistance in Enterobacterales

open access: yesGastroenterology: Medicine & Research, 2022
openaire   +1 more source

Role of Households with Children in Community Spread of Multidrug-Resistant Enterobacterales, St. Louis, Missouri, USA. [PDF]

open access: yesEmerg Infect Dis
Breeze B   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy